About Peckforton Pharmaceuticals
Peckforton Pharmaceuticals is a company based in Cheshire (United States) founded in 1998 was acquired by Intrapharm Labs in August 2014.. Peckforton Pharmaceuticals has raised $1 million across 1 funding round from investors including YFM Equity Partners, Enterprise Ventures and Intrapharm Labs.
- Headquarter Cheshire, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1 M (USD)
in 1 rounds
-
Latest Funding Round
$1 M (USD), Series A
Mar 02, 2012
-
Investors
YFM Equity Partners
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Intrapharm Labs
(Aug 11, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Peckforton Pharmaceuticals
Peckforton Pharmaceuticals has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Series A round of $1 million completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.0M
-
First Round
First Round
(02 Mar 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2012 | Amount | Series A - Peckforton Pharmaceuticals | Valuation | Enterprise Ventures , YFM Equity Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Peckforton Pharmaceuticals
Peckforton Pharmaceuticals has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include YFM Equity Partners, Enterprise Ventures and Intrapharm Labs. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and Growth stage Venture Debt firm that does debt investments in the UK
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
OTC products manufacturer and supplier
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Peckforton Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Peckforton Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Peckforton Pharmaceuticals Comparisons
Competitors of Peckforton Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Peckforton Pharmaceuticals
When was Peckforton Pharmaceuticals founded?
Peckforton Pharmaceuticals was founded in 1998 and raised its 1st funding round 14 years after it was founded.
Where is Peckforton Pharmaceuticals located?
Peckforton Pharmaceuticals is headquartered in Cheshire, United States. It is registered at Cheshire, Connecticut, United States.
Is Peckforton Pharmaceuticals a funded company?
Peckforton Pharmaceuticals is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Series A of $1M, raised on Mar 02, 2012.
What does Peckforton Pharmaceuticals do?
Peckforton Pharmaceuticals manufactures and sells prescription and OTC products for irritable bowel syndrome, indigestion, and heartburn. Products include Kolanticon, a medicine which offers Triple Action Treatment for Irritable Bowel Syndrome and Altacite Plus, an antacid plus antiflatulent for people suffering from heartburn in pregnancy. Other products include Fluconazole for the treatment of infections caused by fungiyeasts, Ciprofloxacin to kill bacteria that causes infection, Ondansetron injection, to prevent and treat nausea caused by chemotherapy or radiotherapy, and Ethambutol tablets are used for the treatment and prevention of tuberculosis. The company was acquired by Abbey Pharma in 2014 and is currently part of the AbbeyIntrapharm Group.
Who are Peckforton Pharmaceuticals's investors?
Peckforton Pharmaceuticals has 3 investors. Key investors include YFM Equity Partners, Enterprise Ventures, and Intrapharm Labs.